Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy
· Delayed Price · Currency is EUR 48.36
-0.14 (-0.29%)
Apr 17, 2025, 5:35 PM CET
Recordati Industria Chimica e Farmaceutica Employees
As of December 31, 2024, Recordati Industria Chimica e Farmaceutica had 4,583 total employees, including 4,495 full-time and 88 part-time employees. The number of employees increased by 128 or 2.87% compared to the previous year.
Employees
4,583
Change (1Y)
128
Growth (1Y)
2.87%
Revenue / Employee
€515,876
Profits / Employee
€91,762
Market Cap
9.98B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| DiaSorin | 3,308 |
| Amplifon | 15,070 |
| Philogen | 165 |
| EL.En. | 2,082 |
| Pharmanutra | 118 |
| Garofalo Health Care | 2,767 |
| Safilo Group | 3,828 |
| GPI S.p.A. | 7,681 |
Recordati Industria Chimica e Farmaceutica News
- 2 months ago - There is still such a huge need to do better with rare diseases: Recordati CEO - CNBC
- 5 months ago - Angelini Pharma Said to Discuss Combination With CVC’s Recordati - BNN Bloomberg
- 5 months ago - Recordati CEO sees 'substantial opportunity' in Sanofi drug purchase - CNBC
- 5 months ago - Recordati SpA (RICFY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 5 months ago - Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Recordati reports nine-month results - Seeking Alpha
- 7 months ago - Sanofi Sells Global Rights To Rare Autoimmume Drug Enjaymo For $825M Upfront To Italian Firm Recordati - Benzinga
- 7 months ago - Recordati buys rights to rare immune disorder drug from Sanofi for $825mln - Zawya